Screener
Kura Oncology KURA Total Assets
Total Assets at other companies
Other financials
Where this comes from
Reported directly by Kura Oncology in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The source filing: Kura Oncology’s 10-Q, filed May 12, 2026.
- Filed
- May 12, 2026, 4:15 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-219481
| Line item | March 31, 2026 | December 31,2025 |
|---|---|---|
| Property and equipment, net | 7,613 | 7,855 |
| Operating lease right-of-use assets | 7,166 | 7,302 |
| Other long-term assets | 13,990 | 14,543 |
| Total assets | $652,551 | $738,363 |
| Liabilities and Stockholders’ Equity | ||
| Current liabilities | ||
| Accounts payable | $7,043 | $5,017 |
| Accrued expenses and other current liabilities | 45,466 | 61,697 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Kura Oncology's total assets?
- Kura Oncology (KURA) reported total assets of $652.55M in Q1 2026.
- How has Kura Oncology's total assets changed year-over-year?
- Kura Oncology's total assets decreased by 12.3% year-over-year, from $743.76M to $652.55M.
- What is the long-term trend for Kura Oncology's total assets?
- Over 5 years (2020 to 2025), Kura Oncology's total assets has grown at a 2.7% compound annual growth rate (CAGR), from $647.21M to $738.36M.
- What does total assets mean?
- The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.
Ask your AI about Kura Oncology's total assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude